Transform Dialysis: Tailored Care or One Approach?

H2 tag- SEO Purpose

Dialysis,CKD

 This article is brought to you by Cresp  

Common Hb targets for Dialysis patient
Common Hb targets for Dialysis patient
Hb targets in predialysis and dialysis patient and role of individualized care
Hb targets in predialysis and dialysis patient and role of individualized care
Hb targets in predialysis and dialysis patient
Hb targets in predialysis and dialysis patient
Difference in Hb targets in predialysis and dialysis patient
Difference in Hb targets in predialysis and dialysis patient
International Guideline of Hb target in CKD
International Guideline of Hb target in CKD
Clinical consideration in CKD patient
Clinical consideration in CKD patient
Individualised Hb targets in CKD patients
Individualised Hb targets in CKD patients

Abbreviations

CKD: Chronic kidney disease; ESA: Erythropoiesis-stimulating agent; Hb: Haemoglobin; Kidney Disease: Improving Global Outcomes

References

1. Nakhoul G, Simon JF. Anemia of chronic kidney disease: Treat it, but not too aggressively. CCJM. 2016;83(8):613–624. 2. NKF KDOQI Guidelines. Available from: https://kidneyfoundation.cachefly.net/professionals/KDOQI/guidelines_anemiaUP /guide1.htm. Accessed on: 21 June 2024. 3. Carrera F, Burnier M. Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations. NDT Plus. 2009;2(Suppl_1):i9-i17. 4. Mimura I, Tanaka T, Nangaku M. How the target hemoglobin of renal anemia should be? Nephron. 2015;131(3):202–209. 5. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney international supplements. 2012; 2(4):279–335.

LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0738

 

Cresp 1

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Cresp